If you would like to know more then please request a representative visit.
PIL, patient information leaflet.
*Correct usage data after reading PIL for Turbohaler® and Easyhaler® were 76.7% and 58.3% respectively (p<0.001, for both comparisons) n=120 for all groups.1 Patients are advised to read the PIL carefully and follow the instructions for use as detailed in the leaflet.
**Dose delivery study using low, middle and high strength DuoResp Spiromax. Dose consistency was measured over inhaler life. Low dose was included in the study but is not licensed in the UK.3
†For 160/4.5mcg strength only.4
‡DuoResp Spiromax is licensed for use in adults 18 years of age and older only.4
§The label on DuoResp Spiromax indicates delivered dose.